InvestorsHub Logo
Followers 133
Posts 24233
Boards Moderated 6
Alias Born 03/03/2013

Re: None

Tuesday, 10/07/2014 9:52:21 AM

Tuesday, October 07, 2014 9:52:21 AM

Post# of 8441
JP Morgan Initiates Novavax At Overweight
Monica Gerson, Benzinga Staff Writer October 07, 2014 8:18 AM

Click For benzinga.com Link


Analysts at JP Morgan initiated coverage on shares of Novavax (NASDAQ: NVAX) with a Overweight rating.

The target price for Novavax is set to $7.

Novavax shares have jumped 37.25% over the past 52 weeks, while the S&P 500 index has gained 18.69% in the same period.

Novavax's shares rose 2.19% to close at $4.20 yesterday.




TRUTH

I've never claimed to have all the answers but feel i'm beginning to corner the market in questions worthy of solutions.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NVAX News